Advertisement
Corrigendum Free access | 10.1172/JCI95841
Find articles by Waqas, S. in: JCI | PubMed | Google Scholar
Find articles by Hoang, A. in: JCI | PubMed | Google Scholar
Find articles by Lin, Y. in: JCI | PubMed | Google Scholar
Find articles by Ampem, G. in: JCI | PubMed | Google Scholar
Find articles by Azegrouz, H. in: JCI | PubMed | Google Scholar
Find articles by Balogh, L. in: JCI | PubMed | Google Scholar
Find articles by Thuróczy, J. in: JCI | PubMed | Google Scholar
Find articles by Chen, J. in: JCI | PubMed | Google Scholar
Find articles by Gerling, I. in: JCI | PubMed | Google Scholar
Find articles by Nam, S. in: JCI | PubMed | Google Scholar
Find articles by Lim, J. in: JCI | PubMed | Google Scholar
Find articles by Martinez-Ibañez, J. in: JCI | PubMed | Google Scholar
Find articles by Real, J. in: JCI | PubMed | Google Scholar
Find articles by Paschke, S. in: JCI | PubMed | Google Scholar
Find articles by Quillet, R. in: JCI | PubMed | Google Scholar
Find articles by Ayachi, S. in: JCI | PubMed | Google Scholar
Find articles by Simonin, F. in: JCI | PubMed | Google Scholar
Find articles by Schneider, E. in: JCI | PubMed | Google Scholar
Find articles by Brinkman, J. in: JCI | PubMed | Google Scholar
Find articles by Lamming, D. in: JCI | PubMed | Google Scholar
Find articles by Seroogy, C. in: JCI | PubMed | Google Scholar
Find articles by Röszer, T. in: JCI | PubMed | Google Scholar
Published July 31, 2017 - More info
The quantity and activation state of adipose tissue macrophages (ATMs) impact the development of obesity-induced metabolic diseases. Appetite-controlling hormones play key roles in obesity; however, our understanding of their effects on ATMs is limited. Here, we have shown that human and mouse ATMs express NPFFR2, a receptor for the appetite-reducing neuropeptide FF (NPFF), and that NPFFR2 expression is upregulated by IL-4, an M2-polarizing cytokine. Plasma levels of NPFF decreased in obese patients and high-fat diet–fed mice and increased following caloric restriction. NPFF promoted M2 activation and increased the proliferation of murine and human ATMs. Both M2 activation and increased ATM proliferation were abolished in NPFFR2-deficient ATMs. Mechanistically, the effects of NPFF involved the suppression of E3 ubiquitin ligase RNF128 expression, resulting in enhanced stability of phosphorylated STAT6 and increased transcription of the M2 macrophage–associated genes IL-4 receptor α (Il4ra), arginase 1 (Arg1), IL-10 (Il10), and alkylglycerol monooxygenase (Agmo). NPFF induced ATM proliferation concomitantly with the increase in N-Myc downstream-regulated gene 2 (Ndrg2) expression and suppressed the transcription of Ifi200 cell-cycle inhibitor family members and MAF bZIP transcription factor B (Mafb), a negative regulator of macrophage proliferation. NPFF thus plays an important role in supporting healthy adipose tissue via the maintenance of metabolically beneficial ATMs.
Syed F. Hassnain Waqas, Anh Cuong Hoang, Ya-Tin Lin, Grace Ampem, Hind Azegrouz, Lajos Balogh, Julianna Thuróczy, Jin-Chung Chen, Ivan C. Gerling, Sorim Nam, Jong-Seok Lim, Juncal Martinez-Ibañez, José T. Real, Stephan Paschke, Raphaëlle Quillet, Safia Ayachi, Frédéric Simonin, E. Marion Schneider, Jacqueline A. Brinkman, Dudley W. Lamming, Christine M. Seroogy, Tamás Röszer
Original citation: J Clin Invest. 2017;127(7):2842–2854. https://doi.org/10.1172/JCI90152
Citation for this corrigendum: J Clin Invest. 2017;127(9):3559. https://doi.org/10.1172/JCI95841
During the assembly of Figure 1D, an incorrect image was inadvertently used for the human omental fat sample. The correct figure panel is below.
The authors regret the error.
See the related article at Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages.